Pancreatic cancer

May 28, 2021
Doctor and patient reviewing test results

Now Enrolling: EA2192/APOLLO for Pancreatic Cancer

This phase II study, led by Dr. Kim Reiss Binder, is exploring whether the addition of maintenance PARP inhibition for BRCA- or PALB2-mutated pancreatic cancer improves outcomes
July 29, 2020

Now Enrolling: EA2186 / GIANT for Advanced Pancreas Cancer in Older Adults

Currently, there is no treatment standard for metastatic pancreatic cancer in people aged 65 years and older